Advances in nanotechnology versus stem cell therapy for the theranostics of Huntington's disease

[1]  H. Kim,et al.  DNA double-strand break-free CRISPR interference delays Huntington’s disease progression in mice , 2023, Communications Biology.

[2]  Vivek P. Chavda,et al.  CAR T-Cell therapy for the management of mantle cell lymphoma , 2023, Molecular Cancer.

[3]  T. G. Singh,et al.  Biomarkers: Role and Scope in Neurological Disorders , 2023, Neurochemical Research.

[4]  M. Collins,et al.  Photo-cross-linkable hyaluronic acid bioinks for bone and cartilage tissue engineering applications , 2023, International Materials Reviews.

[5]  S. Sarantseva,et al.  Fullerenols Prevent Neuron Death and Reduce Oxidative Stress in Drosophila Huntington’s Disease Model , 2022, Cells.

[6]  S. Tiwari,et al.  Detection and modulation of neurodegenerative processes using graphene-based nanomaterials: Nanoarchitectonics and applications. , 2022, Advances in colloid and interface science.

[7]  R. Sheervalilou,et al.  Development and classification of RNA aptamers for therapeutic purposes: an updated review with emphasis on cancer , 2022, Molecular and Cellular Biochemistry.

[8]  A. Murad,et al.  Photo-catalytic and biomedical applications of one-step, plant extract-mediated green-synthesized cobalt oxide nanoparticles , 2022, Environmental science and pollution research international.

[9]  Sonia Fathi Karkan,et al.  siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review , 2022, Cell biology international.

[10]  T. Vellai,et al.  Trehalose-releasing nanogels: A step toward a trehalose delivery vehicle for autophagy stimulation. , 2022, Biomaterials advances.

[11]  Yuan-Lu Cui,et al.  Hydrogen bond-enhanced nanogel delivery system for potential intranasal therapy of Parkinson's Disease , 2022, Materials & Design.

[12]  Y. Choonara,et al.  Advances in designing of polymeric micelles for biomedical application in brain related diseases. , 2022, Chemico-biological interactions.

[13]  J. Patel,et al.  Dendrimer as a versatile platform for biomedical application: A review , 2022, Journal of the Indian Chemical Society.

[14]  Fan Huang,et al.  Engineering a pathological tau-targeted nanochaperone for selective and synergetic inhibition of tau pathology in Alzheimer's Disease , 2022, Nano Today.

[15]  Laura-Jayne A. Ellis,et al.  Daphnia magna and mixture toxicity with nanomaterials – Current status and perspectives in data-driven risk prediction , 2022, Nano Today.

[16]  E. Bézard,et al.  Acidic nanoparticles protect against α‐synuclein‐induced neurodegeneration through the restoration of lysosomal function , 2022, Aging cell.

[17]  Mahdi Rahimi,et al.  Biocompatible functionalized graphene nanosheet for delivery of doxorubicin to breast cancer cells , 2022, Journal of Drug Delivery Science and Technology.

[18]  Buddhadev Layek,et al.  A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics , 2022, International journal of molecular sciences.

[19]  V. Labhasetwar,et al.  Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation , 2022, Antioxidants.

[20]  Kesllin Mariane Gomes Valadão,et al.  Nanotechnology in Improving the Treatment of Huntington’s Disease: a Systematic Review , 2022, Neurotoxicity Research.

[21]  C. Borlongan,et al.  Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders , 2022, International journal of molecular sciences.

[22]  M. Bechelany,et al.  Review on Natural, Incidental, Bioinspired, and Engineered Nanomaterials: History, Definitions, Classifications, Synthesis, Properties, Market, Toxicities, Risks, and Regulations , 2022, Nanomaterials.

[23]  R. Rahbarghazi,et al.  Application of microneedle patches for drug delivery; doorstep to novel therapies , 2022, Journal of tissue engineering.

[24]  S. Srivastava,et al.  Green Nanotechnology: An Overview , 2021, Green Nanoparticles: The Future of Nanobiotechnology.

[25]  S. Ersoy,et al.  Analysis of electroencephalography (EEG) signals and adapting to systems theory principles , 2021, Journal of Complexity in Health Sciences.

[26]  Han Yang,et al.  Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases , 2021, Exploration.

[27]  A. Ilari,et al.  Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin , 2021, Journal of personalized medicine.

[28]  Junxia Xie,et al.  Regulated cell death: discovery, features and implications for neurodegenerative diseases , 2021, Cell Communication and Signaling.

[29]  Luis F González,et al.  Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases , 2021, Pharmaceutics.

[30]  Jiaojiao Zheng,et al.  Inhibiting protein aggregation with nanomaterials: The underlying mechanisms and impact factors. , 2021, Biochimica et biophysica acta. General subjects.

[31]  Md Musavvir Mahmud,et al.  Magnetic Nanoparticle-Mediated Heating for Biomedical Applications. , 2021, Journal of heat transfer.

[32]  C. Riccardi,et al.  Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases , 2021, Pharmaceutics.

[33]  A. Samrot,et al.  Utilizing pharmacological properties of polyphenolic curcumin in nanotechnology , 2021, Biocatalysis and Agricultural Biotechnology.

[34]  J. Cryan,et al.  Modified cyclodextrin-based nanoparticles mediated delivery of siRNA for Huntingtin gene silencing across an in vitro BBB model. , 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[35]  I. Zuhorn,et al.  Aliphatic Quaternary Ammonium Functionalized Nanogels for Gene Delivery , 2021, Pharmaceutics.

[36]  B. Larijani,et al.  Potential for Stem Cell-Based Therapy in the Road of Treatment for Neurological Disorders Secondary to COVID-19 , 2021, Regenerative Engineering and Translational Medicine.

[37]  T. Sakr,et al.  Can nanotechnology overcome challenges facing stem cell therapy? A review , 2021, Journal of Drug Delivery Science and Technology.

[38]  E. Walker,et al.  Nanotechnology for Targeted Detection and Removal of Bacteria: Opportunities and Challenges , 2021, Advanced science.

[39]  Guangyi Wang,et al.  Engineering of anticancer drugs entrapped polymeric nanoparticles for the treatment of colorectal cancer therapy , 2021, Process Biochemistry.

[40]  Toi Van Vo,et al.  Nanotechnology-based drug delivery for central nervous system disorders. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[41]  S. Cavallaro,et al.  Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases? , 2021, Cells.

[42]  P. Brocardo,et al.  New Avenues for the Treatment of Huntington’s Disease , 2021, International journal of molecular sciences.

[43]  Ashagrachew Tewabe Yayehrad,et al.  Could Nanotechnology Help to End the Fight Against COVID-19? Review of Current Findings, Challenges and Future Perspectives , 2021, International journal of nanomedicine.

[44]  P. Praseetha,et al.  Potential eco-friendly Zinc Oxide nanomaterials through Phyco-nanotechnology –A review , 2021 .

[45]  R. Taliyan,et al.  Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB , 2021, Pharmaceutics.

[46]  S. P. Srinivas,et al.  Methods to evaluate the toxicity of engineered nanomaterials for biomedical applications: a review , 2021, Environmental Chemistry Letters.

[47]  Ben M. Maoz,et al.  Biology and Models of the Blood-Brain Barrier. , 2021, Annual review of biomedical engineering.

[48]  K. Adibkia,et al.  Nanomaterials and Stem Cell Differentiation Potential: An Overview of Biological Aspects and Biomedical Efficacy. , 2021, Current Medicinal Chemistry.

[49]  B. Gunasekaran,et al.  The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease , 2021, BioMed research international.

[50]  F. Baino,et al.  Nanomaterials for the Diagnosis and Treatment of Head and Neck Cancers: A Review , 2021, Materials.

[51]  B. Dehay,et al.  PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases , 2021, Pharmaceutics.

[52]  Beibei Ni,et al.  CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure , 2021, Stem Cell Research & Therapy.

[53]  Feng-Dan Zhu,et al.  Nanoparticles: A Hope for the Treatment of Inflammation in CNS , 2021, Frontiers in Pharmacology.

[54]  Kevin Lee,et al.  Directly reprogrammed Huntington's disease neural precursor cells generate striatal neurons exhibiting aggregates and impaired neuronal maturation , 2021, Stem cells.

[55]  Debashree Dutta,et al.  Scope of green nanotechnology towards amalgamation of green chemistry for cleaner environment: A review on synthesis and applications of green nanoparticles , 2021 .

[56]  S. Seal,et al.  Cerium oxide nanomaterial with dual antioxidative scavenging potential: Synthesis and characterization , 2021, Journal of biomaterials applications.

[57]  Z. Asefy,et al.  Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment , 2021, Neurological Sciences.

[58]  M. Essa,et al.  Stem Cells Therapy: A Ray of Hope for Huntington Disease , 2021 .

[59]  S. Mitragotri,et al.  The evolution of commercial drug delivery technologies , 2021, Nature Biomedical Engineering.

[60]  M. Shahrezaee,et al.  Simvastatin-loaded graphene oxide embedded in polycaprolactone-polyurethane nanofibers for bone tissue engineering applications , 2021 .

[61]  Ameya R. Kirtane,et al.  Nanotechnology approaches for global infectious diseases , 2021, Nature Nanotechnology.

[62]  S. Mutalik,et al.  Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases. , 2021, Life sciences.

[63]  Dong-Dong Wu,et al.  The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders , 2021, Frontiers in Bioengineering and Biotechnology.

[64]  Rahul Gauro,et al.  Advances in dendrimer-mediated targeted drug delivery to the brain , 2021, Journal of Nanoparticle Research.

[65]  Farzane Sivandzade,et al.  Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview , 2021, International journal of molecular sciences.

[66]  Z. Bhutta,et al.  Toxicological Consequences of Titanium Dioxide Nanoparticles (TiO2NPs) and Their Jeopardy to Human Population , 2021, BioNanoScience.

[67]  C. Tapeinos.  Graphene‐Based Nanotechnology in Neurodegenerative Disorders , 2021 .

[68]  A. Camins,et al.  Epigallocatechin-3-gallate PEGylated poly(lactic-co-glycolic) acid nanoparticles mitigate striatal pathology and motor deficits in 3-nitropropionic acid intoxicated mice. , 2021, Nanomedicine.

[69]  Gustavo Ruiz-Pulido,et al.  An overview of gastrointestinal mucus rheology under different pH conditions and introduction to pH-dependent rheological interactions with PLGA and chitosan nanoparticles. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[70]  Uttam Pal,et al.  Incorporation of a Biocompatible Nanozyme in Cellular Antioxidant Enzyme Cascade Reverses Huntington's Like Disorder in Preclinical Model , 2020, Advanced healthcare materials.

[71]  Nida S Jalbani,et al.  Fluorescent Nanotechnology: An Evolution in Optical Sensors , 2020, Current Analytical Chemistry.

[72]  M. Salmona,et al.  Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington’s disease , 2020, bioRxiv.

[73]  A. Bachoud-Lévi,et al.  Cell therapy in Huntington's disease: Taking stock of past studies to move the field forward , 2020, Stem cells.

[74]  A. Shavandi,et al.  Iron Oxide Nanoparticles Synthesized Via Green Tea Extract for Doxorubicin Delivery , 2020, Current Nanoscience.

[75]  Z. Gu,et al.  Advances in nanomedicines for diagnosis of central nervous system disorders. , 2020, Biomaterials.

[76]  V. Tkachuk,et al.  Mesenchymal Stromal Cells as Critical Contributors to Tissue Regeneration , 2020, Frontiers in Cell and Developmental Biology.

[77]  Wenhui Song,et al.  Redox-Responsive Nanobiomaterials-Based Therapeutics for Neurodegenerative Diseases. , 2020, Small.

[78]  Falaq Naz,et al.  Nanotechnology: its application in treating Neurodegenerative diseases. , 2020, CNS and Neurological Disorders - Drug Targets.

[79]  R. Pei,et al.  Applications of nanomaterials for scavenging reactive oxygen species in the treatment of central nervous system diseases. , 2020, Journal of materials chemistry. B.

[80]  M. Bilal,et al.  Nanomaterials for the treatment and diagnosis of Alzheimer's disease: An overview , 2020 .

[81]  B. Bay,et al.  Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders , 2020, International journal of molecular sciences.

[82]  Puneet Kumar,et al.  Gene therapy and immunotherapy as promising strategies to combat Huntington’s disease-associated neurodegeneration: emphasis on recent updates and future perspectives , 2020, Expert review of neurotherapeutics.

[83]  M. Narayan,et al.  Application of Nanotechnology in Stem-Cell-Based Therapy of Neurodegenerative Diseases , 2020, Applied Sciences.

[84]  N. Jana,et al.  Small Molecule-Functionalized Hyperbranched Polyglycerol Dendrimer for Inhibiting Protein Aggregation. , 2020, Biomacromolecules.

[85]  M. Narayan,et al.  Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases. , 2020, Biomaterials science.

[86]  M. Kaur,et al.  Engineering nanostructures of CuO-based photocatalysts for water treatment: Current progress and future challenges , 2020 .

[87]  A. Hassanzadeh,et al.  Mesenchymal stromal cells (MSCs) for neurodegenerative disease: A promising frontier. , 2020, European journal of cell biology.

[88]  M. Maaza,et al.  Floral extracts-mediated green synthesis of NiO nanoparticles and their diverse pharmacological evaluations , 2020, Journal of biomolecular structure & dynamics.

[89]  Anubhab Mukherjee,et al.  Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics , 2020, Advanced Functional Materials.

[90]  M. Bilal,et al.  Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis , 2020, Polymers.

[91]  Meijiang Feng,et al.  Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors. , 2020, World journal of stem cells.

[92]  Shobhit Kumar,et al.  Intranasal delivery of tetrabenazine nanoemulsion via olfactory region for better treatment of Hyperkinetic movement associated with Huntington's disease: Pharmacokinetic and brain delivery study. , 2020, Chemistry and physics of lipids.

[93]  A. Koşar,et al.  Therapeutic Nanoparticles and Their Targeted Delivery Applications , 2020, Molecules.

[94]  Xue Xue,et al.  Recent Progress of Nanomedicine in the Treatment of Central Nervous System Diseases , 2020 .

[95]  F. Rizzo,et al.  Neural Stem Cell Transplantation for Neurodegenerative Diseases , 2020, International journal of molecular sciences.

[96]  David R. Bell,et al.  Length-Dependent Structural Transformations of Huntingtin PolyQ Domain Upon Binding to 2D-Nanomaterials , 2020, Frontiers in Chemistry.

[97]  H. Harn,et al.  Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening , 2020, Molecules.

[98]  F. Rousseau,et al.  Nanomaterials to avoid and destroy protein aggregates , 2020, Nano Today.

[99]  C. C. Torres,et al.  Colorimetric determination of cysteamine based on the aggregation of polyvinylpyrrolidone-stabilized silver nanoparticles. , 2020, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[100]  Mohammad Mansoob Khan,et al.  Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure , 2020, Bioprocess and Biosystems Engineering.

[101]  H. Liang,et al.  Neurotoxicity of nanoparticles entering the brain via sensory nerve-to-brain pathways: injuries and mechanisms , 2020, Archives of Toxicology.

[102]  Xu Wang,et al.  Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer’s Disease , 2020, Frontiers in Cellular Neuroscience.

[103]  Yan Deng,et al.  Autophagy Modulated by Inorganic Nanomaterials , 2020, Theranostics.

[104]  S. Jafari,et al.  Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[105]  S. Gopi,et al.  Current advances in the detection of neurotransmitters by nanomaterials: An update , 2020 .

[106]  A. Khvorova,et al.  Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington's disease gene expression following intranasal administration. , 2020, Nanomedicine : nanotechnology, biology, and medicine.

[107]  C. Lopes,et al.  Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[108]  D. Lavery,et al.  Ultrasensitive quantitative measurement of huntingtin phosphorylation at residue S13. , 2020, Biochemical and biophysical research communications.

[109]  Kuldeep Rajpoot.  Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines. , 2020, Current drug targets.

[110]  Boxun Lu,et al.  ATTEC: a potential new approach to target proteinopathies , 2020, Autophagy.

[111]  Hongqi Sun.  Grand Challenges in Environmental Nanotechnology , 2019, Frontiers in Nanotechnology.

[112]  Cláudia Silva,et al.  Quality by Design in Pharmaceutical Manufacturing: a systematic review of current status, challenges and future perspectives. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[113]  T. Ganbold,et al.  Alkylation enhances biocompatibility and siRNA delivery efficiency of cationic curdlan nanoparticles. , 2019, International journal of biological macromolecules.

[114]  M. Hoehn,et al.  In vivo Cell Tracking Using Non-invasive Imaging of Iron Oxide-Based Particles with Particular Relevance for Stem Cell-Based Treatments of Neurological and Cardiac Disease , 2019, Molecular Imaging and Biology.

[115]  M. Karsdal,et al.  A caspase-6-cleaved fragment of Glial Fibrillary Acidic Protein as a potential serological biomarker of CNS injury after cardiac arrest , 2019, PloS one.

[116]  S. de Bot,et al.  Raising Awareness of Therapeutic Misconception and Optimism Around Clinical Trials in Huntington’s Disease , 2019, Journal of Huntington's disease.

[117]  G. Delcroix,et al.  A Combinatorial Cell and Drug Delivery Strategy for Huntington’s Disease Using Pharmacologically Active Microcarriers and RNAi Neuronally-Committed Mesenchymal Stromal Cells , 2019, Pharmaceutics.

[118]  R. Jayant,et al.  In-vitro blood-brain barrier models for drug screening and permeation studies: an overview , 2019, Drug design, development and therapy.

[119]  Hyunjoon Kong,et al.  Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases. , 2019, Biomaterials.

[120]  Liming Wang,et al.  Selenium Nanoparticles as an Efficient Nanomedicine for the Therapy of Huntington's Disease. , 2019, ACS applied materials & interfaces.

[121]  Jialin Meng,et al.  MnFe2O4 nanoparticles accelerate the clearance of mutant huntingtin selectively through ubiquitin-proteasome system. , 2019, Biomaterials.

[122]  S. Kannan,et al.  Nanotechnology enabled regenerative medicine for neurological disorders. , 2019, Advanced Drug Delivery Reviews.

[123]  A. Fatemi,et al.  Translational challenges in advancing regenerative therapy for treating neurological disorders using nanotechnology. , 2019, Advanced drug delivery reviews.

[124]  A. Esmaeili,et al.  Application of quercetin in neurological disorders: from nutrition to nanomedicine , 2019, Reviews in the neurosciences.

[125]  S. P. Srinivas,et al.  Current trends and challenges in cancer management and therapy using designer nanomaterials , 2019, Nano Convergence.

[126]  M. Nair,et al.  Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics , 2019, International journal of nanomedicine.

[127]  M. Salehi,et al.  Will Nanotechnology Bring New Hope for Stem Cell Therapy? , 2019, Cells Tissues Organs.

[128]  S. Karami,et al.  The Role of Nanomaterials in the Treatment of Diseases and Their Effects on the Immune System , 2019, Open access Macedonian journal of medical sciences.

[129]  S. Razavi,et al.  Biodelivery of nerve growth factor and gold nanoparticles encapsulated in chitosan nanoparticles for schwann-like cells differentiation of human adipose-derived stem cells. , 2019, Biochemical and biophysical research communications.

[130]  S. Rouhani,et al.  Electrochemical solid-state nanosensor based on a dual amplification strategy for sensitive detection of (FeIII-dopamine) , 2019, Electrochimica Acta.

[131]  A. Teixeira,et al.  Stem cells in animal models of Huntington disease: A systematic review , 2019, Molecular and Cellular Neuroscience.

[132]  G. Ming,et al.  Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders. , 2019, Advanced drug delivery reviews.

[133]  Wei Li,et al.  Hydrothermal synthesis of nitrogen and boron co-doped carbon quantum dots for application in acetone and dopamine sensors and multicolor cellular imaging , 2019, Sensors and Actuators B: Chemical.

[134]  K. Kalia,et al.  Growing synergy of nanodiamonds in neurodegenerative interventions. , 2019, Drug discovery today.

[135]  Katherine R. Croce,et al.  A role for autophagy in Huntington's disease , 2019, Neurobiology of Disease.

[136]  Pranjal Chandra,et al.  Clinical implications and electrochemical biosensing of monoamine neurotransmitters in body fluids, in vitro, in vivo, and ex vivo models. , 2018, Biosensors & bioelectronics.

[137]  Á. Somoza,et al.  Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment , 2018, Cellular and Molecular Life Sciences.

[138]  N. Jana,et al.  Designed Polymer Micelle for Clearing Amyloid Protein Aggregates via Up-Regulated Autophagy. , 2018, ACS biomaterials science & engineering.

[139]  Haliza Katas,et al.  Biosynthesis and Potential Applications of Silver and Gold Nanoparticles and Their Chitosan-Based Nanocomposites in Nanomedicine , 2018, Journal of Nanotechnology.

[140]  I. Sadowska-Bartosz,et al.  Redox nanoparticles: synthesis, properties and perspectives of use for treatment of neurodegenerative diseases , 2018, Journal of Nanobiotechnology.

[141]  Jianqing Gao,et al.  Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances , 2018, Asian journal of pharmaceutical sciences.

[142]  S. Sahl,et al.  Superresolution Fluorescence Imaging of Mutant Huntingtin Aggregation in Cells. , 2018, Methods in molecular biology.

[143]  Y. Humeau,et al.  Modulation of AMPA receptor surface diffusion restores hippocampal plasticity and memory in Huntington’s disease models , 2018, Nature Communications.

[144]  Ssang-Goo Cho,et al.  The Impact of Metallic Nanoparticles on Stem Cell Proliferation and Differentiation , 2018, Nanomaterials.

[145]  B. Narasimhan,et al.  Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers. , 2018, Nanoscale.

[146]  B. Gulyás,et al.  Theranostic applications of nanoparticles in neurodegenerative disorders , 2018, International journal of nanomedicine.

[147]  Arthur W Toga,et al.  The role of brain vasculature in neurodegenerative disorders , 2018, Nature Neuroscience.

[148]  Reza Salarinia,et al.  Stem cell‐ and gene‐based therapies as potential candidates in Alzheimer's therapy , 2018, Journal of cellular biochemistry.

[149]  F. Mottaghitalab,et al.  siRNA delivery for treatment of degenerative diseases, new hopes and challenges , 2018, Journal of Drug Delivery Science and Technology.

[150]  R. Kamm,et al.  In vitro models of molecular and nano-particle transport across the blood-brain barrier. , 2018, Biomicrofluidics.

[151]  B. Ruozi,et al.  Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain , 2018, International journal of pharmaceutics.

[152]  Xu Zhou,et al.  Recent review of the effect of nanomaterials on stem cells , 2018, RSC advances.

[153]  O. Farokhzad,et al.  Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy. , 2018, Trends in biotechnology.

[154]  Vivek Agrahari,et al.  Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities. , 2018, Drug discovery today.

[155]  Liming Cheng,et al.  Nanomaterials in Neural‐Stem‐Cell‐Mediated Regenerative Medicine: Imaging and Treatment of Neurological Diseases , 2018, Advanced materials.

[156]  S. Tishkoff,et al.  The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[157]  Dong-Ming Huang,et al.  Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson's disease. , 2018, Nanoscale.

[158]  Saleh Khamlich,et al.  Biosynthesis of pure hematite phase magnetic iron oxide nanoparticles using floral extracts of Callistemon viminalis (bottlebrush): their physical properties and novel biological applications , 2018, Artificial cells, nanomedicine, and biotechnology.

[159]  B. Connor.  Concise Review: The Use of Stem Cells for Understanding and Treating Huntington's Disease , 2018, Stem cells.

[160]  M. Shekari Khaniani,et al.  Molecular analysis and prevalence of Huntington disease in northwestern Iran , 2017, Turkish journal of medical sciences.

[161]  M. A. Holgado,et al.  Neuroprotective effect of cannabinoids nanoplatforms in neurodegenerative diseases , 2017 .

[162]  A. Teixeira,et al.  Immunomodulatory Strategies for Huntington's Disease Treatment. , 2017, CNS & neurological disorders drug targets.

[163]  M. Farah.  The Neuroscience of Socioeconomic Status: Correlates, Causes, and Consequences , 2017, Neuron.

[164]  A. Teixeira,et al.  Promises and pitfalls of immune-based strategies for Huntington's disease , 2017, Neural regeneration research.

[165]  Fang Chen,et al.  Photoacoustic Imaging of Human Mesenchymal Stem Cells Labeled with Prussian Blue-Poly(l-lysine) Nanocomplexes. , 2017, ACS nano.

[166]  Rıfat Emrah Özel,et al.  Metabolic and transcriptomic analysis of Huntington’s disease model reveal changes in intracellular glucose levels and related genes , 2017, Heliyon.

[167]  Rassoul Dinarvand,et al.  Application of modelling and nanotechnology‐based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders , 2017, Life sciences.

[168]  T. Pringsheim,et al.  Risk factors for the onset and progression of Huntington disease , 2017, Neurotoxicology.

[169]  Eran A Barnoy,et al.  The effect of nanoparticle size on the ability to cross the blood-brain barrier: an in vivo study. , 2017, Nanomedicine.

[170]  A. Angelova,et al.  Structural analysis of nanoparticulate carriers for encapsulation of macromolecular drugs , 2017 .

[171]  Matheus Bertanha,et al.  Effects of Canine and Murine Mesenchymal Stromal Cell Transplantation on Peripheral Nerve Regeneration , 2017, International journal of stem cells.

[172]  C. Bhattacharjee,et al.  Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases , 2017, International Nano Letters.

[173]  B. Narasimhan,et al.  Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[174]  Qianli Zou,et al.  Self‐Assembled Peptide‐ and Protein‐Based Nanomaterials for Antitumor Photodynamic and Photothermal Therapy , 2017, Advanced materials.

[175]  B. Song.  In Vivo Assessment of Stem Cells for Treating Neurodegenerative Disease: Current Approaches and Future Prospects , 2017, Stem cells international.

[176]  Toi Van Vo,et al.  Sonication-Assisted Nanoprecipitation in Drug Delivery. , 2017, Current drug metabolism.

[177]  Tai Hyun Park,et al.  Human Dopamine Receptor-Conjugated Multidimensional Conducting Polymer Nanofiber Membrane for Dopamine Detection. , 2016, ACS applied materials & interfaces.

[178]  V. Préat,et al.  NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[179]  Joshua A. Zimmermann,et al.  Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon‐γ Within Three‐Dimensional Mesenchymal Stem Cell Constructs , 2016, Stem cells translational medicine.

[180]  Wei Feng,et al.  Optimization of Prussian Blue Coated NaDyF4:x%Lu Nanocomposites for Multifunctional Imaging‐Guided Photothermal Therapy , 2016 .

[181]  Muhammad Shafiq,et al.  Insight on stem cell preconditioning and instructive biomaterials to enhance cell adhesion, retention, and engraftment for tissue repair. , 2016, Biomaterials.

[182]  Sen Lu,et al.  MicroRNA-4262 activates the NF-κB and enhances the proliferation of hepatocellular carcinoma cells. , 2016, International journal of biological macromolecules.

[183]  Barbara Ruozi,et al.  Nanoparticle transport across the blood brain barrier , 2016, Tissue barriers.

[184]  M. Longaker,et al.  An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs , 2016, International journal of molecular sciences.

[185]  Mohammad A Kamal,et al.  Nanoparticles, Neurotoxicity and Neurodegenerative Diseases. , 2015, Current drug metabolism.

[186]  N. Staff,et al.  A safety study on intrathecal delivery of autologous mesenchymal stromal cells in rabbits directly supporting Phase I human trials , 2015, Transfusion.

[187]  Aditi Falnikar,et al.  Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury. , 2015, World journal of stem cells.

[188]  Sona Zare,et al.  Types of Stem Cells in Regenerative Medicine: A Review , 2014 .

[189]  M. Kamal,et al.  Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders. , 2014, Current drug metabolism.

[190]  S. Bajjalieh,et al.  Huntingtin is associated with cytomatrix proteins at the presynaptic terminal , 2014, Molecular and Cellular Neuroscience.

[191]  Matheus B. Victor,et al.  Generation of Human Striatal Neurons by MicroRNA-Dependent Direct Conversion of Fibroblasts , 2014, Neuron.

[192]  J. Weinman,et al.  Detecting acute distress and risk of future psychological morbidity in critically ill patients: validation of the intensive care psychological assessment tool , 2014, Critical Care.

[193]  W. Cui,et al.  Sox2, a key factor in the regulation of pluripotency and neural differentiation. , 2014, World journal of stem cells.

[194]  Adem Yildirim,et al.  Turn-on fluorescent dopamine sensing based on in situ formation of visible light emitting polydopamine nanoparticles. , 2014, Analytical chemistry.

[195]  Mark T. Harnett,et al.  An optimized fluorescent probe for visualizing glutamate neurotransmission , 2013, Nature Methods.

[196]  Krystyna Jackowska,et al.  New trends in the electrochemical sensing of dopamine , 2012, Analytical and Bioanalytical Chemistry.

[197]  Tobias Wittkop,et al.  Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells. , 2012, Cell stem cell.

[198]  S. Y. Chew,et al.  Directing stem cell fate by controlled RNA interference. , 2012, Biomaterials.

[199]  J. Nolta,et al.  Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin , 2012, Molecular and Cellular Neuroscience.

[200]  Alexander M. Seifalian,et al.  Toxicology and clinical potential of nanoparticles , 2011, Nano today.

[201]  J. Hur,et al.  Stem cell technology for neurodegenerative diseases , 2011, Annals of neurology.

[202]  Jane S. Paulsen.  Cognitive Impairment in Huntington Disease: Diagnosis and Treatment , 2011, Current neurology and neuroscience reports.

[203]  R. de Caterina,et al.  Stem cells and growth factor delivery systems for cardiovascular disease. , 2011, Journal of biotechnology.

[204]  J. Malva,et al.  Controlling the neuronal differentiation of stem cells by the intracellular delivery of retinoic acid-loaded nanoparticles. , 2011, ACS Nano.

[205]  Reid L Skeel,et al.  Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease , 2010, Behavioural Brain Research.

[206]  K. L. Martinez,et al.  Glutamate Monitoring In Vitro and In Vivo : Recent Progress in the Field of Glutamate Biosensors , 2009 .

[207]  Jesse K. Biehl,et al.  Introduction to Stem Cell Therapy , 2009, The Journal of cardiovascular nursing.

[208]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[209]  V. Torchilin,et al.  "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. , 2006, Bioconjugate chemistry.

[210]  M. Frame,et al.  Src in cancer: deregulation and consequences for cell behaviour. , 2002, Biochimica et biophysica acta.

[211]  Jane S. Paulsen,et al.  Clinical markers of early disease in persons near onset of Huntington’s disease , 2001, Neurology.

[212]  Tae-Hyung Kim,et al.  Graphene-Based Materials for Efficient Neurogenesis. , 2022, Advances in experimental medicine and biology.

[213]  Smriti Ojha,et al.  Neuroprotective Potential of Dimethyl Fumarate-loaded Polymeric Nanoparticles against Multiple Sclerosis , 2019, Indian Journal of Pharmaceutical Sciences.

[214]  T. Vinther-Jensen,et al.  Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment. , 2019, Journal of Huntington's disease.

[215]  K. Sugaya,et al.  Stem Cell Therapies for Neurodegenerative Diseases. , 2018, Advances in experimental medicine and biology.

[216]  N. Jana,et al.  Poly(trehalose) Nanoparticles Prevent Amyloid Aggregation and Suppress Polyglutamine Aggregation in a Huntington's Disease Model Mouse. , 2017, ACS applied materials & interfaces.

[217]  J. Majoral,et al.  Can dendrimer based nanoparticles fight neurodegenerative diseases? Current situation versus other established approaches , 2017 .

[218]  M. Hayden,et al.  Epidemiology of Huntington disease. , 2017, Handbook of clinical neurology.

[219]  D. Arifin,et al.  In Vivo Micro‐CT Imaging of Human Mesenchymal Stem Cells Labeled with Gold‐Poly‐l‐Lysine Nanocomplexes , 2017, Advanced functional materials.

[220]  E. Wild,et al.  Cerebrospinal Fluid Biomarkers for Huntington's Disease. , 2016, Journal of Huntington's disease.

[221]  E. Hoveizi,et al.  In Vitro Differentiation of Human iPS Cells into Neural like Cells on a Biomimetic Polyurea , 2015, Molecular Neurobiology.

[222]  K. Turksen,et al.  Stem Cell Niche , 2013, Methods in Molecular Biology.